EzriCare class action claims products contaminated with bacteria

EzriCare class action overview: 

• Who: EzriCare is facing a class action lawsuit over its eye drops that were contaminated with bacteria. 
• Why: The bacteria contamination was the result of EzriCare’s poor manufacturing processes and the company should have known about the issues, the lawsuit says.
• Where: The EzriCare bacteria class action was filed in federal court in New Jersey.

EzriCare is facing a class action lawsuit claiming that poor manufacturing processes led to its eye drops becoming contaminated with a rare and dangerous bacteria.

The EzriCare bacteria contamination came from a rare strain of Pseudomonas aeruginosa that was not previously seen in the U.S. The contamination was the result of the company not following the U.S. Food and Drug Administration’s (FDA) Current Good Manufacturing Processes, the lawsuit claims.

“Defendants knew or should have known that this Bacteria was ever present and needed to be eradicated from any source of water and should have ensured such was done,” the EzriCare lawsuit says. “But instead, through its actions or inactions, defendants EzriCare chose to allow the bacteria to exist in its products.”

EzriCare bacteria recall came on Feb. 1, week after CDC eye drops investigation was announced

EzriCare first issued a statement on Jan. 24 that the U.S. Centers for Disease Control and Prevention was investigating its eye drops. The company then issued a statement and recalled the eye drops Feb. 1.

The FDA then issued a warning about the products on Feb. 2, the EzriCare lawsuit says.

The class is asking to stop EzriCare from selling its eye drops, suggesting they are effective for their intended use and from implying the eye drops are effective. The class also asks for a corrective ad campaign, injunctive relief, damages and restitution and the return of any benefits from selling the contaminated eye drops.

A Pennsylvania woman needed to have one of her eyeballs surgically removed after she contracted a bacterial infection from using EzriCare Artificial Tears, an eye drop product she purchased on Amazon.com, an August lawsuit alleges. 

Have you purchased EzriCare eye drops? Let us know in the comments.

The plaintiff is represented by Philip Furia of The Sultzer Law Group PC, along with Paul J. Doolittle and Blake G. Abbott of Poulin Willey Anastopoulo LLC.

The EzriCare class action lawsuit is Roberts v. EzriCare LLC, et al., Case No. 3:23-cv-22827, in the U.S. District Court for the District of New Jersey.

Read About More Class Action Lawsuits & Class Action Settlements:

• Recall issued for eye drops sold at Rite Aid, CVS, others due to sanitation issues
• FDA warns consumers against using eye drops from many major brands
• CVS eye drops class action claims product falsely advertised as safe, effective
• Albertsons class action alleges company falsely advertises lidocaine patch benefits